Jupiter Asset Management LTD Amneal Pharmaceuticals, Inc. Transaction History

Jupiter Asset Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$2.02 - $3.62 $15,412 - $27,620	-7,630 Reduced 0.77%	979,648 $1.98 Million
Q2 2022 Aug 10, 2022	SELL	$3.01 - $4.46 $10,763 - $15,948	-3,576 Reduced 0.36%	987,278 $3.14 Million
Q1 2022 May 11, 2022	BUY	$3.9 - $4.89 $123,704 - $155,105	31,719 Added 3.31%	990,854 $4.12 Million
Q4 2021 Feb 11, 2022	BUY	$3.95 - $5.85 $452,275 - $669,825	114,500 Added 13.56%	959,135 $4.66 Million
Q3 2021 Nov 10, 2021	SELL	$4.31 - $5.64 $140,596 - $183,982	-32,621 Reduced 3.72%	844,635 $4.5 Million
Q2 2021 Aug 10, 2021	BUY	$5.12 - $6.82 $927,431 - $1.24 Million	181,139 Added 26.02%	877,256 $4.49 Million
Q1 2021 May 12, 2021	BUY	$4.74 - $7.38 $3.3 Million - $5.14 Million	696,117 New	696,117 $4.69 Million

183

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.21B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.